MRC National Institute for Medical Research, London

• Home
• Publications
• Influenza Bibliography

• Annual Report and Prospectus
• Latest publications
• Influenza Bibliography
• Mill Hill Essays

Influenza Bibliography

April 2010 : Vol 40 No 4

Categories

• Clinical
• Diagnosis and detection
• Epidemiology
• Immunology and immunity
• Pandemics - planning and threats
• Structure, function and genetics
• Therapies and antivirals
• Vaccination and vaccines

Clinical

• Anonymous. (2010),
  How do you know whether it's flu?
  Harvard Health Letter 35(3), 3.
• Anonymous. (2010),
  Is it a cold or the flu?
  Consumer Reports 75(2), 14.
• Anonymous. (2009),
  The lastest on H1N1.
  Queensland Nurse 28(5), 24.
• Anonymous. (2010),
  Preparations enable children's EDs to effectively handle H1N1 surge.
  ED Management 22(3), 25-7.
• Ambrosini, JJ and King, B. (2009),
  "Swine" flu: a new challenge.
  Diabetes Self-Management 26(6), 68-71.
• Anderson, T, Capua, I, Dauphin, G, Donis, R, Fouchier, R, Mumford, E, Peiris, M, Swayne, D and Thiermann, A. (2010),
  FAO-OIE-WHO Joint Technical Consultation on Avian Influenza at the Human-Animal Interface.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 1-29.
• Aviram, G, Bar-Shai, A, Sosna, J, Rogowski, O, Rosen, G, Weinstein, I, Steinvil, A and Zimmerman, O. (2010),
  H1N1 influenza: initial chest radiographic findings in helping predict patient outcome.
  Radiology 255(1), 252-259.
• Baillie, J. (2010),
  Controlled humidity could hit flu hard.
  Health Estate 64(2), 53-7.
• Balicer, RD, Anis, E, Goldmann, D, Dahan, D, Singer, R and Grotto, I. (2010),
  [Influenza A/H1N1 in Israel--clinical and epidemiological characteristics].
  Harefuah 148(11), 738-42.
• Balkhy, HH, Abolfotouh, MA, Al-Hathlool, RH and Al-Jumah, MA. (2010),
  Awareness, attitudes, and practices related to the swine influenza pandemic among the Saudi public.
  BMC Infectious Diseases 10, 42.
• Barker, K. (2010),
  Canadian First Nations experience with H1N1: new lessons or perennial issues?
  International Journal of Tuberculosis & Lung Disease 14(2), 130.
• Bramley, AM, Bresee, J and Finelli, L. (2009),
  Pediatric influenza.
  Pediatric Nursing 35(6), 335-45.
• Bratincsak, A, El-Said, HG, Bradley, JS, Shayan, K, Grossfeld, PD and Cannavino, CR. (2010),
  Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children.
  Journal of the American College of Cardiology 55(9), 928-9.
• Brown, J. (2010),
  Prevent flu with a healthy dose of fruits and vegetables.
  CDS Review 103(1), 28.
• Bundy, DG, Strouse, JJ, Casella, JF and Miller, MR. (2010),
  Burden of influenza-related hospitalizations among children with sickle cell disease.
  Pediatrics 125(2), 234-243.
• Castro, KG, Bell, BP and Schuchat, A. (2010),
  Preventing complications from 2009 influenza A (H1N1) in persons with underlying lung diseases: a formidable challenge for 2010 Year of the Lung.
  International Journal of Tuberculosis & Lung Disease 14(2), 127-9.
• Chen, BY, Chang, HH, Chen, ST, Tsao, ZJ, Yeh, SM, Wu, CY and Lin, DPC. (2009),
  Congenital eye malformations associated with extensive periocular neural crest apoptosis after influenza B virus infection during early embryogenesis.
  Molecular Vision 15(298-99), 2821-2828.
• Cheng, VCC, Tai, JWM, Wong, LMW, Chan, JFW, Li, IWS, To, KKW, Hung, IFN, Chan, KH, Ho, PL and Yuen, KY. (2010),
  Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle.
  Journal of Hospital Infection 74(3), 271-277.
• Chien, Y-S, Su, C-P, Tsai, H-T, Huang, AS, Lien, C-E, Hung, M-N, Chuang, J-H, Kuo, H-S and Chang, S-C. (2010),
  Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan.
  Journal of Infection 60(2), 168-74.
• Cowling, BJ, Zhou, Y, Ip, DKM, Leung, GM and Aiello, AE. (2010),
  Face masks to prevent transmission of influenza virus: a systematic review.
  Epidemiology & Infection 138(4), 449-56.
• Crovari, P and Gasparini, R. (2009),
  Influenza pandemic AH1N1v/2009--early experience and autumn perspectives.
  Journal of Preventive Medicine & Hygiene 50(2), 77-8.
• Cruz, AT, Patel, B, DiStefano, MC, Codispoti, CR, Shook, JE, Demmler-Harrison, GJ and Sirbaugh, PE. (2010),
  Outside the box and into thick air: implementation of an exterior mobile pediatric emergency response team for North American H1N1 (swine) influenza virus in Houston, Texas.
  Annals of Emergency Medicine 55(1), 23-31.
• Cunha, BA. (2010),
  Swine influenza (H1N1) pneumonia during the 'herald wave' of the pandemic: no increase in bacterial pneumonia without empirical antibiotics.
  International Journal of Antimicrobial Agents 35(2), 200-1.
• Cunha, BA. (2010),
  Swine infuenza (H1N1) pneumonia: bacterial airway colonization common but fatalities due to bacterial pneumonia remain relatively rare.
  Journal of Clinical Virology 47(2), 199-200.
• Cunha, BA, Syed, U and Strollo, S. (2010),
  Swine influenza (H1N1) pneumonia: elevated serum procalcitonin levels not due to superimposed bacterial pneumonia.
  International Journal of Antimicrobial Agents 35(5), 515-516.
• Dilantika, C, Sedyaningsih, ER, Kasper, MR, Agtini, M, Listiyaningsih, E, Uyeki, TM, Burgess, TH, Blair, PJ and Putnam, SD. (2010),
  Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness.
  BMC Infectious Diseases 10, 3.
• Doyle, A, Carter, J and Young, P. (2009),
  Swine flu: provision of ventilation in a worst-case scenario.
  Critical Care (London, England) 13(5), 422.
• Dubar, G, Launay, O, Batteux, F, Tsatsaris, V, Goffinet, F and Mignon, A. (2010),
  Pregnancy and pandemic influenza A(H1N1) 2009. Current concepts for anaesthesia and critical care medicine.
  Annales Francaises D Anesthesie Et De Reanimation 29(2), 126-134.
• Eisenhut, M. (2010),
  Comment on: swine flu and antibiotics.
  Journal of Antimicrobial Chemotherapy 65(2), 377; author reply 378.
• Eisenhut, M. (2009),
  Procalcitonin measurement to reduce antibiotic use in influenza.
  Biosecurity & Bioterrorism 7(4), 453-4.
• Elliott, EJ. (2010),
  Pregnancy and pandemic flu.
  Clinical Infectious Diseases 50(5), 691-2.
• Ellner, K, Lanternier, F, Simons de Fanti, A and Consigny, PH. (2010),
  [Influenza virus A/H1N1 infection: wrong provisional diagnosis.[corrected]].
  Deutsche Medizinische Wochenschrift 135(7), 290-2.
• Erben, N, Kartal, ED, Alpat, SN, Ozgunes, I and Usluer, G. (2010),
  A case of pneumonia following human infection with avian influenza a (H5N1).
  Central European Journal of Medicine 5(1), 59-61.
• Fouchier, RAM. (2010),
  Influenza virus infectivity, pathogenicity, and transmissibility in humans.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 33.
• Franklin, N. (2009),
  Sovereignty and international politics in the negotiation of the avian influenza Material Transfer Agreement.
  Journal of Law & Medicine 17(3), 355-72.
• Frolic, A, Kata, A and Kraus, P. (2009),
  Development of a critical care triage protocol for pandemic influenza: integrating ethics, evidence and effectiveness.
  Healthcare Quarterly 12(4), 54-62.
• Fumagalli, LL and Lazzarin, A. (2009),
  Influenza A (H1N1) virus infection in Intensive Care Unit: the point of view of the infectious diseases consultant.
  Minerva Anestesiologica 75(11), 599-601.
• Gilmour, D. (2009),
  Swine flu--are you ready?
  Journal of Perioperative Practice 19(12), 404.
• Green, M and Allen, U. (2010),
  H1N1 influenza A 2009 and pediatric transplantation: lessons learned and to be learned.
  Pediatric Transplantation 14(1), 1-5.
• Guarner, J and Falcon-Escobedo, R. (2009),
  Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
  Archives of Medical Research 40(8), 655-661.
• Guo, HH, Sweeney, RT, Regula, D and Leung, AN. (2010),
  Best cases from the AFIP fatal 2009 influenza A (H1N1) infection, complicated by acute respiratory distress syndrome and pulmonary interstitial emphysema.
  Radiographics 30(2), 327-333.
• Gustafson, K. (2009),
  H1N1 in pregnancy: the wound care team called to action.
  Advances in Skin & Wound Care 22(12), 542.
• Haktanir, A. (2010),
  MR imaging in novel influenza A(H1N1)-associated meningoencephalitis.
  American Journal of Neuroradiology 31(3), 394-395.
• Harder, TC and Vahlenkamp, TW. (2010),
  Influenza virus infections in dogs and cats.
  Veterinary Immunology and Immunopathology 134(1-2), 54-60.
• Hartshorn, KL. (2010),
  New look at an old problem: bacterial superinfection after influenza.
  American Journal of Pathology 176(2), 536-9.
• Hay, A. (2010),
  WHO process for monitoring novel influenza viruses.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 36.
• Hernandez, JM. (2010),
  Infecting dose can explain different severity of cases in new influenza A (H1N1).
  Medical Hypotheses 74(3), 617.
• Hernandez, JM. (2010),
  Platelet dysfunction can be the hidden risk factor for death in new influenza A (H1N1).
  Medical Hypotheses 74(2), 392-3.
• Hewagama, S, Walker, SP, Stuart, RL, Gordon, C, Johnson, PDR, Friedman, ND, O'Reilly, M, Cheng, AC and Giles, ML. (2010),
  2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia.
  Clinical Infectious Diseases 50(5), 686-90.
• Ho, A, Fox, R, Seaton, RA, MacConnachie, A, Peters, E, Mackintosh, CL, Todd, WTA, Kennedy, N, Dundas, S and Gunson, R. (2010),
  Hospitalised adult patients with suspected 2009 H1N1 infection at Regional Infectious Diseases Units in Scotland--most had alternative final diagnoses.
  Journal of Infection 60(1), 83-5.
• Hopkins, BS, Johnson, KE, Ksiazek, JM, Sun, G, Greinwald, JH and Rutter, M. (2010),
  H1N1 influenza A presenting as bacterial tracheitis.
  Otolaryngology-Head and Neck Surgery 142(4), 612-614.
• Horai, Y, Miyamura, T, Takahama, S, Sonomoto, K, Nakamura, M, Ando, H, Minami, R, Yamamoto, M and Suematsu, E. (2010),
  Influenza virus B-associated hemophagocytic syndrome and recurrent pericarditis in a patient with systemic lupus erythematosus.
  Modern Rheumatology 20(2), 178-182.
• Horby, P. (2010),
  Why are so few people infected with influenza A (H5N1) despite a large exposed population? The role of host genetics.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 40.
• Inusa, B, Zuckerman, M, Gadong, N, Afif, M, Arnott, S, Heath, P, Marais, G, Robertson, P, Payne, H, Wilkey, O and Rees, DC. (2010),
  Pandemic influenza A (H1N1) virus infections in children with sickle cell disease.
  Blood 115(11), 2329-30.
• Jaber, S, Conseil, M, Coisel, Y, Jung, B and Chanques, G. (2010),
  ARDS and influenza A (H1N1): patients characteristics and management in intensive care unit. A literature review.
  Annales Francaises D Anesthesie Et De Reanimation 29(2), 117-125.
• Jameel, S. (2010),
  The 2009 influenza pandemic.
  Current Science 98(3), 306-311.
• Jeon, EJ, Kim, KH and Min, KH. (2010),
  Acute eosinophilic pneumonia associated with 2009 influenza A (H1N1).
  Thorax 65(3), 268-270.
• Jia, X, Zhang, Y-Y and Ma, X-H. (2008),
  [Chest X-ray manifestation of children with infection of highly pathogenic H5 avian influenza virus].
  Zhejiang da Xue Xue Bao Yi Xue Ban [Journal of Zhejiang University. Medical Sciences] 37(3), 312-4.
• Joanna, SM, Agnieszka, F, Andrzej, S, Zenon, P, Krzysztof, B, Marek, P and Piotr, K. (2010),
  Severe A/H1N1 influenza in four pregnant women in Podkarpacie Province of Poland.
  Ginekologia Polska 81(3), 227-231.
• Johnson, BF, Wilson, LE, Ellis, J, Elliot, AJ, Barclay, WS, Pebody, RG, McMenamin, J, Fleming, DM and Zambon, MC. (2009),
  Fatal cases of influenza a in childhood.
  PLoS ONE 4(10), e7671.
• Kannegieter, NJ, Schaaf, KL, Lovell, DK, Simon, CD and Stone, BM. (2010),
  Myofibroblastic fibrosarcoma with multifocal osseous metaplasia at the site of equine influenza vaccination.
  Australian Veterinary Journal 88(4), 132-136.
• Kharfan-Dabaja, MA, Velez, A, Richards, K, Greene, JN, Field, T and Sandin, R. (2010),
  Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population.
  International Journal of Hematology 91(1), 124-7.
• Kosugi, N, Tsurutani, Y, Isonishi, A, Hori, Y, Matsumoto, M and Fujimura, Y. (2010),
  Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor.
  Internal Medicine 49(7), 689-693.
• Lai, AR, Keet, K, Yong, CM and Diaz, JV. (2010),
  Severe H1N1-Associated acute respiratory distress syndrome: a case series.
  American Journal of Medicine 123(3), 282-U24.
• Lai, C-C, Wang, C-Y and Lin, H-I. (2010),
  Rhabdomyolysis and acute kidney injury associated with 2009 pandemic influenza A(H1N1).
  American Journal of Kidney Diseases 55(3), 615.
• Lapinsky, SE. (2010),
  Critical illness as a result of influenza A/H1N1 infection in pregnancy.
  British Medical Journal 340, c1235.
• Larson, EL, Ferng, Y-h, Wong-McLoughlin, J, Wang, S, Haber, M and Morse, SS. (2010),
  Impact of non-pharmaceutical interventions on URIs and influenza in crowded, urban households.
  Public Health Reports 125(2), 178-91.
• Leggat, PA, Speare, R and Aitken, P. (2009),
  Swine flu and travelers: an Australian perspective.
  Journal of Travel Medicine 16(6), 373-6.
• Malchikov, IA, Glinskikh, NP, Tuzankina, IA, Grigoryeva, JV, Slobodenyuk, VK and Tulakina, LG. (2009),
  Experimental modeling of viral diseases of the locomotor system.
  Bulletin of Experimental Biology and Medicine 148(4), 631-633.
• Martin, A and Reade, EP. (2010),
  Acute necrotizing encephalopathy progressing to brain death in a pediatric patient with novel influenza A (H1N1) infection.
  Clinical Infectious Diseases 50(8), E50-E52.
• McKenna, M. (2010),
  Pearls about swine how emergency departments are coping with the surge of H1N1.
  Annals of Emergency Medicine 55(1), A19-21.
• Morgan, OW, Bramley, A, Fowlkes, A, Freedman, DS, Taylor, TH, Gargiullo, P, Belay, B, Jain, S, Cox, C, Kamimoto, L, Fiore, A, Finelli, L, Olsen, SJ and Fry, AM. (2010),
  Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease.
  PLoS ONE 5(3), e9694.
• Mukhopadhyay, S, Philip, AT and Stoppacher, R. (2010),
  Pathologic findings in novel influenza A (H1N1) virus ("Swine Flu") infection: contrasting clinical manifestations and lung pathology in two fatal cases.
  American Journal of Clinical Pathology 133(3), 380-7.
• Murray, JS. (2010),
  A collaborative approach to meeting the psychosocial needs of children during an influenza pandemic.
  Journal for Specialists in Pediatric Nursing 15(2), 135-143.
• Nam, HV and Nguyen, T. (2010),
  Summary of animal health information relevant to human exposure to highly pathogenic avian influenza H5N1 in Vietnam.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 41-42.
• Noymer, A, Carreon, D and Johnson, N. (2010),
  Questioning the salicylates and influenza pandemic mortality hypothesis in 1918-1919.
  Clinical Infectious Diseases 50(8), 1203.
• Opal, SM. (2009),
  Coming soon to an ICU near you: severe pandemic influenza in ICU patients in Spain.
  Critical Care (London, England) 13(5), 196.
• O'Riordan, S, Barton, M, Yau, Y, Read, SE, Allen, U and Tran, D. (2010),
  Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza.
  CMAJ Canadian Medical Association Journal 182(1), 39-44.
• Ormitti, F, Ventura, E, Summa, A, Picetti, E and Crisi, G. (2010),
  Acute necrotizing encephalopathy in a child during the 2009 influenza A(H1N1) pandemia: MR imaging in diagnosis and follow-up.
  American Journal of Neuroradiology 31(3), 396-400.
• Palacios, G, Hornig, M, Cisterna, D, Savji, N, Bussetti, AV, Kapoor, V, Hui, J, Tokarz, R, Briese, T, Baumeister, E and Lipkin, WI. (2009),
  Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza.
  PLoS ONE 4(12), e8540.
• Parcevaux, M, Antok, E, Boisson, V, Grabel, C, Bugnon, O and Winer, A. (2010),
  Acute respiratory distress due to influenza A (H1N1) S-OIV and extracorporeal oxygenation: the benefit of a multidisciplinary care network.
  Annales Francaises D Anesthesie Et De Reanimation 29(2), 145-148.
• Pittet, LA, Hall-Stoodley, L, Rutkowski, MR and Harmsen, AG. (2010),
  Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae.
  American Journal of Respiratory Cell and Molecular Biology 42(4), 450-460.
• Redelman-Sidi, G, Sepkowitz, KA, Huang, CK, Park, S, Stiles, J, Eagan, J, Perlin, DS, Pamer, EG and Kamboj, M. (2010),
  2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients.
  Journal of Infection 60(4), 257-263.
• Robertson, M. (2009),
  Open questions about influenza A (H1N1) 2009.
  Journal of Biology 8(8), 68.
• Saenz, RA, Quinlivan, M, Elton, D, MacRae, S, Blunden, AS, Mumford, JA, Daly, JM, Digard, P, Cullinane, A, Grenfell, BT, McCauley, JW, Wood, JLN and Gog, JR. (2010),
  Dynamics of influenza virus infection and pathology.
  Journal of Virology 84(8), 3974-3983.
• Samaan, G. (2010),
  Avian influenza H5N1 and the World Health Organization's support to implementation of the Healthy Food Markets Strategy in Indonesia.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 39-40.
• Scott, A, More, R and Freebairn, RC. (2010),
  Tongue swelling complicating management of a ventilated patient with acute respiratory distress syndrome secondary to novel influenza A (H1N1).
  Anaesthesia and Intensive Care 38(2), 370-372.
• Seppelt, I. (2010),
  Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study.
  British Medical Journal 340, c1279.
• Shanmugam, RS and Shankar, S. (2009),
  Swine flu: need to adopt safety measures.
  Nursing Journal of India 100(8), 176-8.
• Sharon, B and Schleiss, MR. (2009),
  Pandemic Influenza A (H1N1).
  Pediatric Research 66(6), 599.
• Shu, Y, Li, CK-f, Li, Z, Gao, R, Liang, Q, Zhang, Y, Dong, L, Zhou, J, Dong, J, Wang, D, Wen, L, Wang, M, Bai, T, Li, D, Dong, X, Yu, H, Yang, W, Wang, Y, Feng, Z, McMichael, AJ and Xu, X-N. (2010),
  Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues.
  Journal of Infectious Diseases 201(8), 1173-7.
• Siregar, ES. (2010),
  Summary of animal health information relevant to human exposure to avian influenza H5N1 in Indonesia.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 41.
• Smoot, MK and Hosey, RG. (2009),
  Pulmonary Infections in the Athlete.
  Current Sports Medicine Reports 8(2), 71-75.
• Subbarao, I, Rubinson, L and James, JJ. (2009),
  H1N1: revealing the collective resolve of medicine and public health.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S93-4.
• Troppmann, C, Cohen, S, de Mattos, A and Perez, R. (2010),
  Rapidly progressive lethal infection with novel influenza A (H1N1) 2009 virus in a kidney recipient: a cautionary tale.
  Transplantation 89(3), 369-70.
• Van, D, McLaws, ML, Crimmins, J, MacIntyre, CR and Seale, H. (2010),
  University life and pandemic influenza: attitudes and intended behaviour of staff and students towards pandemic (H1N1) 2009.
  BMC Public Health 10, 130.
• van der Meer, FJUM, Orsel, K and Barkema, HW. (2010),
  The new influenza A H1N1 virus: balancing on the interface of humans and animals.
  Canadian Veterinary Journal 51(1), 56-62.
• Vessey, JA and Turner-Henson, A. (2010),
  Back to the future: H1N1 and public health.
  Journal of Pediatric Nursing 25(1), 1-2.
• Watanabe, T and Kawashima, H. (2010),
  Primary pyomyositis following influenza A virus infection and vigorous exercise.
  Pediatrics International 52(2), e96-e97.
• White, JR. (2009),
  H1N1.
  Journal of the Kentucky Medical Association 107(12), 479.
• Wiwanitkit, V. (2010),
  Obstetrical concern on new emerging swine flu.
  Archives of Gynecology & Obstetrics 281(2), 369.
• Yokoyama, T, Tsushima, K, Ushiki, A, Kobayashi, N, Urushihata, K, Koizumi, T and Kubo, K. (2010),
  Acute lung injury with alveolar hemorrhage due to a novel swine-origin influenza A (H1N1) virus.
  Internal Medicine 49(5), 427-430.
• Zheng, YS, Yang, YF, Zhao, W and Wang, H. (2010),
  Case report: novel swine-origin influenza A (H1N1) virus-associated hemophagocytic syndrome-A first case report.
  American Journal of Tropical Medicine and Hygiene 82(4), 743-745.

Back to top

Diagnosis and detection

• Alper, CM, Li-Korotky, HS, Lo, CY, Doyle, APC, Winther, B and Doyle, WJ. (2010),
  Nasal secretion concentrations of IL-5, IL-6, and IL-10 in children with and without upper respiratory tract viruses.
  Archives of Otolaryngology-Head & Neck Surgery 136(3), 281-286.
• Ayeyard, J, Hedegaard, T, Bilenberg, B and Nicolau, DV. (2010),
  Microfabricated magnetic bead polydimethylsiloxane microarrays.
  Microelectronic Engineering 87(5-8), 760-764.
• Biere, B, Bauer, B and Schweiger, B. (2010),
  Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR.
  Journal of Clinical Microbiology 48(4), 1425-1427.
• Campbell, AP, Chien, JW, Kuypers, J, Englund, JA, Wald, A, Guthrie, KA, Corey, L and Boeckh, M. (2010),
  Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.
  Journal of Infectious Diseases 201(9), 1404-1413.
• Cruz, AT, Demmler-Harrison, GJ, Caviness, AC, Buffone, GJ and Revell, PA. (2010),
  Performance of a rapid influenza test in children during the H1N1 2009 influenza a outbreak.
  Pediatrics 125(3), e645-50.
• Dhiman, N, Espy, MJ, Irish, C, Wright, P, Smith, TF and Pritt, BS. (2010),
  Mutability in the matrix gene of novel influenza A H1N1 virus detected using a FRET probe-based real-time reverse transcriptase PCR assay.
  Journal of Clinical Microbiology 48(2), 677-9.
• Dovas, CI, Papanastassopoulou, M, Georgiadis, MP, Chatzinasiou, E, Maliogka, VI and Georgiades, GK. (2010),
  Detection and quantification of infectious avian influenza A (H5N1) virus in environmental water by using real-time reverse transcription-PCR.
  Applied and Environmental Microbiology 76(7), 2165-2174.
• Hawkes, M, Richardson, SE, Ipp, M, Schuh, S, Adachi, D and Tran, D. (2010),
  Sensitivity of rapid influenza diagnostic testing for swine-origin 2009 a (H1N1) influenza virus in children.
  Pediatrics 125(3), e639-44.
• Leonardi, GP, Mitrache, I, Pigal, A and Freedman, L. (2010),
  Public hospital-based laboratory experience during an outbreak of pandemic influenza A (H1N1) virus infections.
  Journal of Clinical Microbiology 48(4), 1189-1194.
• Lippi, G and Plebani, M. (2010),
  Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype?
  Clinical Chemistry & Laboratory Medicine 48(1), 1-5.
• Louie, RF, Kitano, T, Brock, TK, Derlet, R and Kost, GJ. (2009),
  Point-of-care testing for pandemic influenza and biothreats.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S193-202.
• Matsui, T, Hakozaki, Y, Suzuki, S, Usui, T, Kato, T, Hasegawa, K, Sugiyama, Y, Sugamata, M and Abe, S. (2010),
  A novel screening method for influenza patients using a newly developed non-contact screening system.
  Journal of Infection 60(4), 271-277.
• Moreno, DMS, Napoles, RC and Arriaga, JMP. (2010),
  Comparison of two diagnostic methods for the detection of the porcine influenza virus.
  Veterinaria Mexico 41(1), 45-58.
• Ong, AK, Chen, MI, Lin, L, Tan, AS, Nwe, NW, Barkham, T, Tay, SY and Leo, YS. (2009),
  Improving the clinical diagnosis of influenza--a comparative analysis of new influenza A (H1N1) cases.
  PLoS ONE 4(12), e8453.
• Pourmand, N, Diamond, L, Garten, R, Erickson, JP, Kumm, J, Donis, RO and Davis, RW. (2006),
  Rapid and highly informative diagnostic assay for H5N1 influenza viruses.
  PLoS ONE 1, e95.
• Watcharananan, S, Kiertiburanakul, S and Chantratita, W. (2010),
  Rapid influenza diagnostic test during the outbreak of the novel influenza A/H1N1 2009 in Thailand: an experience with better test performance in resource limited setting.
  Journal of Infection 60(1), 86-7.
• Weiss, EA, Ngo, J, Gilbert, GH and Quinn, JV. (2010),
  Drive-through medicine: a novel proposal for rapid evaluation of patients during an influenza pandemic.
  Annals of Emergency Medicine 55(3), 268-73.
• Wittman, V, Byers, A, Drake, D, Kachurina, O, Tapia, T, Warren, W and Kachurin, A. (2010),
  New tests for an old foe: an update on influenza screening.
  Idrugs 13(4), 248-253.
• Zakria, I and Crawfurd, J. (2010),
  Rapid influenza testing of febrile children in the Emergency Department.
  Emergency Medicine Journal 27(3), 243-245.

Back to top

Epidemiology

• Aly, MM, Arafa, A, Slim, AA and Hassan, MK. (2010),
  Overview on epidemiological surveillances of highly pathogenic avian influenza viruses (H5N1) from 2006-2008 in Egypt.
  Influenza and Other Respiratory Viruses 4(Suppl 1), 41.
• Bamberg, W, Finkner, N, Guppy, D, Simmerly, D, Clement, E, Kogut, S, Schaffzin, JK, Flore, A, Srinivasan, A, Stone, N, Kallen, A and Hocevar, S. (2010),
  Outbreaks of 2009 pandemic influenza A (H1N1) among long-term-care facility residents-three states, 2009 (Reprinted from MMWR, vol 59, pg 74-77, 2010).
  JAMA-Journal of the American Medical Association 303(12), 1142-1144.
• Barry, JM. (2009),
  Observations on past influenza pandemics.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S95-9.
• Belser, JA, Tumpey, TM, Katz, JM and Swayne, DE. (2010),
  Possible transmission modes for avian influenza viruses to people: studies in experimental models.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 38.
• Bos, MEH, Beest, DET, van Boven, M, Holle, M, Meijer, A, Bosman, A, Mulder, YM, Koopmans, MPG and Stegeman, A. (2010),
  High probability of avian influenza virus (H7N7) transmission from poultry to humans active in disease control on infected farms.
  Journal of Infectious Diseases 201(9), 1390-1396.
• Briand, S. (2010),
  Overview of human cases of avian influenza since 1997.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 31.
• Brown, IH. (2010),
  Animal outbreaks with H5N1 highly pathogenic avian influenza globally since 1997.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 31.
• Caley, P, Becker, NG and Philp, DJ. (2007),
  The waiting time for inter-country spread of pandemic influenza.
  PLoS ONE 2(1), e143.
• Capua, I and Alexander, D. (2010),
  Circulation of non-H5N1 subtype avian influenza viruses with zoonotic potential.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 32.
• Centers for Disease Control and Prevention. (2010),
  2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care - New York City, 2009.
  MMWR - Morbidity & Mortality Weekly Report 59(11), 321-6.
• Chen, H and Martin, V. (2010),
  Summary of animal health information relevant to human exposure to avian influenza H5N1 in China.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 40-41.
• Chen, MIC, Lee, VJM, Lim, W-Y, Barr, IG, Lin, RTP, Koh, GCH, Yap, J, Cui, L, Cook, AR, Laurie, K, Tan, LWL, Tan, BH, Loh, J, Shaw, R, Durrant, C, Chow, VTK, Kelso, A, Chia, KS and Leo, YS. (2010),
  2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore.
  JAMA 303(14), 1383-91.
• Chen, S-C and Liao, C-M. (2010),
  Probabilistic indoor transmission modeling for influenza (sub)type viruses.
  Journal of Infection 60(1), 26-35.
• Cohen, J. (2010),
  What's old is new: 1918 virus matches 2009 H1N1 strain.
  Science 327(5973), 1563-4.
• Deo, MG. (2009),
  Host factors in swine flu pandemic in India.
  Indian Journal of Medical Research 130(6), 772-3.
• Dill, CE and Favata, MA. (2009),
  Novel influenza A (H1N1) outbreak on board a US navy vessel.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S117-20.
• Ebrahim, GJ. (2010),
  Swine flu (S-OIV) pandemic.
  Journal of Tropical Pediatrics 56(1), 1-3.
• Franco-Paredes, C, Hernandez-Ramos, I, Del Rio, C, Alexander, KT, Tapia-Conyer, R and Santos-Preciado, JI. (2009),
  H1N1 influenza pandemics: comparing the events of 2009 in Mexico with those of 1976 and 1918-1919.
  Archives of Medical Research 40(8), 669-672.
• Fraser, C. (2007),
  Estimating individual and household reproduction numbers in an emerging epidemic.
  PLoS ONE 2(1), e758.
• Gresham, L, Ramlawi, A, Briski, J, Richardson, M and Taylor, T. (2009),
  Trust across borders: responding to 2009 H1N1 influenza in the Middle East.
  Biosecurity & Bioterrorism 7(4), 399-404.
• Grijalva-Otero, I, Talavera, JO, Solorzano-Santos, F, Vazquez-Rosales, G, Vladislavovna-Doubova, S, Perez-Cuevas, R, Miranda-Novales, G, Garcia-Pena, C, Espinel-Bermudez, C, Torres, J and de la Pena, JE. (2009),
  Critical analysis of deaths due to atypical pneumonia during the onset of the influenza A (H1N1) virus epidemic.
  Archives of Medical Research 40(8), 662-668.
• Guleria, R. (2009),
  The H1N1 2009 pandemic: who is afraid of the big bad wolf?
  National Medical Journal of India 22(5), 225-7.
• Jiang, X and Cooper, GF. (2010),
  A real-time temporal Bayesian architecture for event surveillance and its application to patient-specific multiple disease outbreak detection.
  Data Mining and Knowledge Discovery 20(3), 328-360.
• Katriel, G and Stone, L. (2010),
  Pandemic dynamics and the breakdown of herd immunity.
  PLoS ONE 5(3), e9565.
• Kim, HR, Park, CK, Lee, YJ, Woo, GH, Lee, KK, Oem, JK, Kim, SH, Jean, YH, Bae, YC, Yoon, SS, Roh, IS, Jeong, OM, Kim, HY, Choi, JS, Byun, JW, Song, YK, Kwon, JH and Joo, YS. (2010),
  An outbreak of highly pathogenic H5N1 avian influenza in Korea, 2008.
  Veterinary Microbiology 141(3-4), 362-366.
• Kim, MC, Jeong, OM, Kang, HM, Paek, MR, Kwon, JS, Song, CS, Kwon, YK, Lee, JG, Kwon, JH and Lee, YJ. (2010),
  Pathogenicity and transmission studies of H7N7 avian influenza virus isolated from feces of magpie origin in chickens and magpie.
  Veterinary Microbiology 141(3-4), 268-274.
• Klinkenberg, D, Fraser, C and Heesterbeek, H. (2006),
  The effectiveness of contact tracing in emerging epidemics.
  PLoS ONE 1, e12.
• Kowalczyk, A and Markowska-Daniel, I. (2010),
  Phylogenetic analysis of swine influenza viruses isolated in Poland.
  Polish Journal of Veterinary Sciences 13(1), 37-44.
• Kwan-Gett, TS, Baer, A and Duchin, JS. (2009),
  Spring 2009 H1N1 influenza outbreak in King County, Washington.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S109-16.
• Lee, BE, Mukhi, SN and Drews, SJ. (2010),
  Association between patient age and influenza A subtype during influenza outbreaks.
  Infection Control and Hospital Epidemiology 31(5), 535-537.
• Leibler, JH, Carone, M and Silbergeld, EK. (2010),
  Contribution of company affiliation and social contacts to risk estimates of between-farm transmission of avian influenza.
  PLoS ONE 5(3), e9888.
• Magalhaes, RJS, Ortiz-Pelaez, A, Kim, LLT, Quoc, HD, Otte, J and Pfeiffer, DU. (2010),
  Associations between attributes of live poultry trade and HPAI H5N1 outbreaks: a descriptive and network analysis study in northern Vietnam.
  BMC Veterinary Research 6, 10.
• Miller, E, Hoschler, K, Hardelid, P, Stanford, E, Andrews, N and Zambon, M. (2010),
  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
  Lancet 375(9720), 1100-1108.
• Minh, PQ, Stevenson, MA, Schauer, B, Morris, RS and Quy, TD. (2010),
  A description of the management of itinerant grazing ducks in the Mekong River δ of Vietnam.
  Preventive Veterinary Medicine 94(1-2), 101-107.
• Mumford, E and Arget, M. (2010),
  World Health Organization data on potential sources of human exposure to avian influenza H5N1 virus.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 38-39.
• Niang, MN, Diop, OM, Sarr, FD, Goudiaby, D, Malou-Sompy, H, Ndiaye, K, Vabret, A and Baril, L. (2010),
  Viral etiology of respiratory infections in children under 5 years old living in tropical rural areas of Senegal: the EVIRA Project.
  Journal of Medical Virology 82(5), 866-872.
• Nukiwa, N, Kamigaki, T, Hashimoto, A, Kawamura, M, Tamaki, R and Oshitani, H. (2010),
  [Epidemiological study of health impact on influenza outpatients during 2008-2009 influenza season, Shonai, Yamagata].
  Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases 84(1), 52-8.
• Pariani, E, Frati, ER, Amendola, A, Zappa, A, Bianchi, S, Colzani, D, Canuti, M, Brambilla, D, Zanetti, A and Tanzi, E. (2009),
  Molecular characterization and phylogenetic analysis of human influenza A viruses in three consecutive seasons with different epidemiological profiles.
  Journal of Preventive Medicine & Hygiene 50(2), 113-6.
• Peiris, JSM and Guan, Y. (2010),
  Potential role of live poultry markets and the environment in human exposure to avian influenza viruses.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 39.
• Perdue, ML. (2010),
  Accurate surveillance and characterization of avian influenza viruses and development of counter measures for pandemic influenza.
  Influenza and Other Respiratory Viruses 4(Suppl 1), 32.
• Potdar, VA, Chadha, MS, Jadhav, SM, Mullick, J, Cherian, SS and Mishra, AC. (2010),
  Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India.
  PLoS ONE 5(3), e9693.
• Qiang, XL and Kou, Z. (2009),
  Prediction of interspecies transmission for avian influenza A virus based on BP neural network.
  2009 Fourth International Conference on Bio-Inspired Computing: Theories and Applications, Proceedings, 146-148.
• Ramirez, AP, Mendoza, AR, Montoya, JM, Cotes, K, Lopez, JD, Herrera, D, Rey, G and de la Hoz, F. (2009),
  [Mortality associated with peak seasons of influenza virus circulation in Bogota, Colombia, 1997-2005].
  Pan American Journal of Public Health 26(5), 435-9.
• Rodriguez-Alvarez, M, Velasco-Velasco, AM, Alvarez-Anell, NJ, Jimenez-Corona, ME and de Leon-Rosales, SP. (2009),
  Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.
  Archives of Medical Research 40(8), 687-692.
• Sekkides, O. (2010),
  Infectious disease surveillance update: influenza.
  Lancet Infectious Diseases 10(3), 150.
• Shapiro, JS, Genes, N, Kuperman, G, Chason, K and Richardson, LD. (2010),
  Health information exchange, biosurveillance efforts, and emergency department crowding during the Spring 2009 H1N1 outbreak in New York City.
  Annals of Emergency Medicine 55(3), 274-279.
• Smith, AM, Adler, FR and Perelson, AS. (2010),
  An accurate two-phase approximate solution to an acute viral infection model.
  Journal of Mathematical Biology 60(5), 711-726.
• Stirling, AC and Scoones, I. (2009),
  From risk assessment to knowledge mapping: science, precaution, and participation in disease ecology.
  Ecology and Society 14(2), 14.
• Suwannakarn, K, Chieochansin, T, Thongmee, C, Makkoch, J, Praianantathavorn, K, Theamboonlers, A, Sreevatsan, S and Poovorawan, Y. (2010),
  Molecular evolution of human H1N1 and H3N2 influenza A virus in Thailand, 2006-2009.
  PLoS ONE 5(3), e9717.
• Takeuchi, S and Kuroda, Y. (2010),
  [Predicting spread of new pandemic swine-origin influenza A (H1N1) in local mid-size city: evaluation of hospital bed shortage and effectiveness of vaccination].
  Nippon Eiseigaku Zasshi - Japanese Journal of Hygiene 65(1), 48-52.
• Tsubokura, M, Nakada, H, Matsumura, T, Kodama, Y and Kami, M. (2010),
  The impact of H1N1 influenza A virus pandemic on the emergency medical service in Kobe.
  American Journal of Emergency Medicine 28(2), 248-51.
• Turner, KB and Levy, MH. (2010),
  Prison outbreak: pandemic (H1N1) 2009 in an Australian prison.
  Public Health 124(2), 119-21.
• Williams, CJ, Schweiger, B, Diner, G, Gerlach, F, Haaman, F, Krause, G, Nienhaus, A and Buchholz, U. (2010),
  Seasonal influenza risk in hospital healthcare workers is more strongly associated with household than occupational exposures: results from a prospective cohort study in Berlin, Germany, 2006/07.
  BMC Infectious Diseases 10, 8.
• Wilson, JM, Iannarone, M and Wang, C. (2009),
  Media reporting of the emergence of the 1968 influenza pandemic in Hong Kong: implications for modern-day situational awareness.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S148-53.
• Xiang, NJ, Shi, Y, Wu, JB, Zhang, SX, Ye, M, Peng, ZB, Zhou, L, Zhou, H, Liao, QH, Huai, Y, Li, LL, Yu, ZD, Cheng, XW, Su, WK, Wu, XM, Ma, HW, Lu, JH, McFarland, J and Yu, HJ. (2010),
  Knowledge, attitudes and practices (KAP) relating to avian influenza in urban and rural areas of China.
  BMC Infectious Diseases 10, 34.
• Yamaguchi, N, Hupp, JW, Higuchi, H, Flint, PL and Pearce, JM. (2010),
  Satellite-tracking of Northern Pintail Anas acuta during outbreaks of the H5N1 virus in Japan: implications for virus spread.
  Ibis 152(2), 262-271.
• Yang, YL. (2009),
  A geometrical analysis of the avian influenza virus at different areas.
  2009 International Conference on Engineering Computation, 229-231.
• Yeskey, K. (2009),
  Effective pandemic preparedness.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S91-2.
• Yingst, S. (2007),
  A veterinary comparative medicine officer's dream assignment.
  US Army Medical Department Journal, 38-43.
• Yip, MP, Ong, B, Painter, I, Meischke, H, Calhoun, B and Tu, SP. (2009),
  Information-seeking behaviors and response to the H1N1 outbreak in Chinese limited-English proficient individuals living in King County, Washington.
  American Journal of Disaster Medicine 4(6), 353-60.
• Zaman, RU, Alamgir, ASM, Rahman, M, Azziz-Baumgartner, E, Gurley, ES, Sharker, MAY, Brooks, WA, Azim, T, Fry, AM, Lindstrom, S, Gubareva, LV, Xu, X, Garten, RJ, Hossain, MJ, Khan, SU, Faruque, LI, Ameer, SS, Klimov, AI, Rahman, M and Luby, SP. (2009),
  Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008.
  PLoS ONE 4(12), e8452.
• Zaporozhan, V and Ponomarenko, A. (2010),
  Mechanisms of geomagnetic field influence on gene expression using influenza as a model system: basics of physical epidemiology.
  International Journal of Environmental Research and Public Health 7(3), 938-965.

Back to top

Immunology and immunity

• Achdout, H, Meningher, T, Hirsh, S, Glasner, A, Bar-On, Y, Gur, C, Porgador, A, Mendelson, M, Mandelboim, M and Mandelboim, O. (2010),
  Killing of avian and Swine influenza virus by natural killer cells.
  Journal of Virology 84(8), 3993-4001.
• Barber, MRW, Aldridge, JR, Webster, RG and Magor, KE. (2010),
  Association of RIG-I with innate immunity of ducks to influenza.
  Proceedings of the National Academy of Sciences of the United States of America 107(13), 5913-5918.
• Chapman, TJ and Topham, DJ. (2010),
  Identification of a unique population of tissue-memory CD4(+) T cells in the airways after influenza infection that is dependent on the integrin VLA-1.
  Journal of Immunology 184(7), 3841-3849.
• Desmet, EA, Hollenbaugh, JA, Sime, PJ, Wright, TW, Topham, DJ, Sant, AJ, Takimoto, T, Dewhurst, S and Maggirwar, SB. (2010),
  Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells.
  Virology 400(2), 224-232.
• Giamarellos-Bourboulis, EJ, Raftogiannis, M, Antonopoulou, A, Baziaka, F, Koutoukas, P, Savva, A, Kanni, T, Georgitsi, M, Pistiki, A, Tsaganos, T, Pelekanos, N, Athanassia, S, Galani, L, Giannitsioti, E, Kavatha, D, Kontopidou, F, Mouktaroudi, M, Poulakou, G, Sakka, V, Panagopoulos, P, Papadopoulos, A, Kanellakopoulou, K and Giamarellou, H. (2009),
  Effect of the novel influenza A (H1N1) virus in the human immune system.
  PLoS ONE 4(12), e8393.
• Huber, VC, Peltola, V, Iverson, AR and McCullers, JA. (2010),
  Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications.
  Journal of Virology 84(8), 4105-4108.
• Jamali, A, Sabahi, F, Bamdad, T, Hashemi, H, Mahboudi, F and Kheiri, MT. (2010),
  A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model.
  Clinical and Vaccine Immunology 17(4), 683-687.
• Kedzierska, K, Valkenburg, SA, Guillonneau, C, Hubert, FX, Cukalac, T, Curtis, JM, Stambas, J, Scott, HS, Kedzierski, L, Venturi, V and Davenport, MP. (2010),
  Diversity and clonotypic composition of influenza-specific CD8(+) TCR repertoires remain unaltered in the absence of Aire.
  European Journal of Immunology 40(3), 849-858.
• Liu, XD, Xiang, AL, Fang, MD, Cao, Y, Wu, ZF and Zhao, SH. (2010),
  QTL and association analysis of Mx1 gene with economic traits in commercial pigs.
  Journal of Animal and Veterinary Advances 9(4), 774-778.
• McCarty, MF, Barroso-Aranda, J and Contreras, F. (2010),
  Practical strategies for targeting NF-kappaB and NADPH oxidase may improve survival during lethal influenza epidemics.
  Medical Hypotheses 74(1), 18-20.
• Naghieh, A, Toghyani, M, Gheisari, AA, Saeed, SE and Miranzadeh, H. (2010),
  Effect of different sources of supplemental Chromium on performance and immune responses of broiler chicks.
  Journal of Animal and Veterinary Advances 9(2), 354-358.
• Olson, MR, Russ, BE, Doherty, PC, Turner, SJ and Stambas, J. (2010),
  Influenza A virus-specific CD8(+) T-cell responses: from induction to function.
  Future Virology 5(2), 175-183.
• Reemers, SS, Veldhuizen, EJA, Fleming, C, van Haarlem, DA, Haagsman, H and Vervelde, L. (2010),
  Transcriptional expression levels of chicken collectins are affected by avian influenza A virus inoculation.
  Veterinary Microbiology 141(3-4), 379-384.
• Reiche, S, Bussmann, BM, Dwai, Y and Jassoy, C. (2010),
  Antibody-mediated binding of fluorescent HIV Gag and influenza nucleoprotein tetramers to blood cells.
  Immunobiology 215(3), 223-229.
• Salimi, N, Fleri, W, Peters, B and Sette, A. (2010),
  Design and utilization of epitope-based databases and predictive tools.
  Immunogenetics 62(4), 185-196.
• Singla, RK and Bhat, VG. (2010),
  Honey bee sting and venom offering active as well as passive immunization could reduce swine flu pandemic A (H1N1).
  Medical Hypotheses 74(3), 617-618.
• Sun, Y, Liu, J, Yang, M, Gao, F, Zhou, J, Kitamura, Y, Gao, B, Tien, P, Shu, Y, Iwamoto, A, Chen, Z and Gao, GF. (2010),
  Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.
  Journal of General Virology 91(Pt 4), 919-30.
• Takagi, Y, Kurihara, S, Higashi, N, Morikawa, S, Kase, T, Maeda, A, Arisaka, H, Shibahara, S and Akiyama, Y. (2010),
  Combined administration of L-cystine and L-theanine enhances immune functions and protects against influenza virus infection in aged mice.
  Journal of Veterinary Medical Science 72(2), 157-165.
• Theodossis, A, Guillonneau, C, Welland, A, Ely, LK, Clements, CS, Williamson, NA, Webb, AI, Wilce, JA, Mulder, RJ, Dunstone, MA, Doherty, PC, McCluskey, J, Purcell, AW, Turner, SJ and Rossjohn, J. (2010),
  Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
  Proceedings of the National Academy of Sciences of the United States of America 107(12), 5534-5539.
• Yamashita, A, Kawashita, N, Kubota-Koketsu, R, Inoue, Y, Watanabe, Y, Ibrahim, MS, Ideno, S, Yunoki, M, Okuno, Y, Takagi, T, Yasunaga, T and Ikuta, K. (2010),
  Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
  Biochemical and Biophysical Research Communications 393(4), 614-618.
• Yan, S and Wu, G. (2010),
  Evidence for cross-species infections and cross-subtype mutations in influenza a matrix proteins.
  Viral Immunology 23(1), 105-11.

Back to top

Pandemics - planning and threats

• Anderson, ED and Hodge, JG, Jr. (2009),
  Emergency legal preparedness among select US local governments.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S176-84.
• Barnett, DJ, Levine, R, Thompson, CB, Wijetunge, GU, Oliver, AL, Bentley, MA, Neubert, PD, Pirrallo, RG, Links, JM and Balicer, RD. (2010),
  Gauging US emergency medical services workers' willingness to respond to pandemic influenza using a threat- and efficacy-based assessment framework.
  PLoS ONE 5(3), e9856.
• Barrett, C, Bisset, K, Leidig, J, Marathe, A and Marathe, M. (2010),
  An integrated modeling environment to study the coevolution of networks, individual behavior, and epidemics.
  AI Magazine 31(1), 75-87.
• Beaman, MH and Leung, MJ. (2010),
  Pandemic influenza testing at the coalface: time for reassessment?
  Medical Journal of Australia 192(2), 102-4.
• Bourlon, MT, Macias, AE, de la Torre, A, Gulias-Herrero, A, Leal, PE, Dominguez-Cherit, G, Huertas, M and Ruiz-Palacios, GM. (2009),
  Organization of a third-level care hospital in Mexico City during the 2009 influenza epidemic.
  Archives of Medical Research 40(8), 681-686.
• Burger, R. (2009),
  [Maintenance of the supply of blood products in the event of an influenza pandemic].
  Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 52(12), 1210-22.
• Cusick, C. (2010),
  Disaster and flu: putting planning into practice.
  Materials Management in Health Care 19(1), 14-8.
• Daugherty, EL, Carlson, AL and Perl, TM. (2010),
  Planning for the inevitable: preparing for epidemic and pandemic respiratory illness in the shadow of H1N1 influenza.
  Clinical Infectious Diseases 50(8), 1145-1154.
• Del Rio, C and Hernandez-Avila, M. (2009),
  Lessons from previous influenza pandemics and from the Mexican response to the current influenza pandemic.
  Archives of Medical Research 40(8), 677-680.
• DeLaurentis, PCC, Adida, E and Lawley, M. (2009),
  Hospital stockpiling for influenza pandemics with pre-determined response levels.
  Proceedings of 2009 Ieee International Conference on Service Operation, Logistics and Informatics, 37-42.
• Goldstein, E, Apolloni, A, Lewis, B, Miller, JC, Macauley, M, Eubank, S, Lipsitch, M and Wallinga, J. (2010),
  Distribution of vaccine/antivirals and the 'least spread line' in a stratified population.
  Journal of the Royal Society Interface 7(46), 755-764.
• Hall, JN, Moore, S and Shiell, A. (2010),
  Assessing the congruence between perceived connectivity and network centrality measures specific to pandemic influenza preparedness in Alberta.
  BMC Public Health 10, 124.
• Hanfling, D and Hick, JL. (2009),
  Hospitals and the novel H1N1 outbreak: the mouse that roared?
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S100-6.
• Haworth, E, Rashid, H and Booy, R. (2010),
  Prevention of pandemic influenza after mass gatherings - learning from Hajj.
  Journal of the Royal Society of Medicine 103(3), 79-80.
• Hilpusch, F. (2010),
  [Pandemic preparedness seen from the district medical officer's office].
  Tidsskrift for Den Norske Laegeforening 130(6), 590.
• Hupert, N, Xiong, W, King, K, Castorena, M, Hawkins, C, Wu, C and Muckstadt, JA. (2009),
  Uncertainty and operational considerations in mass prophylaxis workforce planning.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S121-31.
• Kinlaw, K, Barrett, DH and Levine, RJ. (2009),
  Ethical guidelines in pandemic influenza: recommendations of the Ethics Subcommittee of the Advisory Committee of the Director, Centers for Disease Control and Prevention.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S185-92.
• Levin, D, Cadigan, RO, Biddinger, PD, Condon, S, Koh, HK and Joint Massachusetts Department of Public Health-Harvard Altered Standards of Care Working Group. (2009),
  Altered standards of care during an influenza pandemic: identifying ethical, legal, and practical principles to guide decision making.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S132-40.
• Litchfield, SM. (2010),
  A new Occupational Safety and Health Administration directive regarding H1N1 influenza in the workplace.
  AAOHN Journal 58(1), 3-4.
• Monahan, C, Ullberg, L and Harvey, K. (2009),
  Virtual Emergency Preparedness Planning using Second Life.
  Proceedings of 2009 Ieee International Conference on Service Operation, Logistics and Informatics, 306-310.
• Pena, FG, Fernandez, LAL and Garcia, EG. (2009),
  [Influenza A from the rational choice theory: proposals for decision making in prevention policies].
  Revista Espanola de Salud Publica 83(6), 785-90.
• Radonovich, LJ, Jr., Perl, TM, Davey, V and Cohen, H. (2009),
  Preventing the soldiers of health care from becoming victims on the pandemic battlefield: respirators or surgical masks as the armor of choice.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S203-10.
• Rappuoli, R, Medini, D, Siena, E, Budroni, S, Dormitzer, PR and Del Giudice, G. (2010),
  Building an insurance against modern pandemics.
  Current Opinion in Investigational Drugs 11(2), 126-30.
• Ringel, JS, Moore, M, Zambrano, J and Lurie, N. (2009),
  Will routine annual influenza prevention and control systems serve the United States well in a pandemic?
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S160-5.
• Ritvo, P, Wilson, K, Gibson, JL, Guglietti, C, Tracy, CS, Nie, JX, Jadad, AR and Upshur, REG. (2010),
  Canadian survey on pandemic flu preparations.
  BMC Public Health 10, 125.
• Santos-Preciado, J, Franco-Paredes, C, Hernandez-Flores, I, Tellez, I, Del Rio, C and Tapia-Conyer, R. (2009),
  What have we learned from the novel influenza A (H1N1) pandemic in 2009 for strengthening pandemic influenza preparedness?
  Archives of Medical Research 40(8), 673-676.
• Scanlon, J, Casey, H and McMahon, T. (2009),
  Almost only women: Canadian volunteer response to the 1918-1920 pandemic.
  American Journal of Disaster Medicine 4(6), 331-43.
• Shabanowitz, RB and Reardon, JE. (2009),
  Avian flu pandemic - flight of the healthcare worker?
  HEC Forum 21(4), 365-85.
• Smith, EC, Burkle, FM, Jr., Holman, PF, Dunlop, JM and Archer, FL. (2009),
  Lessons from the front lines: the prehospital experience of the 2009 novel H1N1 outbreak in Victoria, Australia.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S154-9.
• Smith, PW, Smith, AW and Meza, JL. (2009),
  Influenza preparedness in Nebraska assisted living facilities.
  Biosecurity & Bioterrorism 7(4), 429-32.
• Starko, KM. (2010),
  Questioning the salicylates and influenza pandemic mortality hypothesis in 1918-1919 reply.
  Clinical Infectious Diseases 50(8), 1203-1204.
• Usher, K, Gardner, A, Buttner, P, Woolley, T, Sando, J, White, K and West, C. (2009),
  The H1N1 influenza 09 and its potential impact on the Australian nursing workforce.
  Collegian: Journal of the Royal College of Nursing, Australia 16(4), 169-70.

Back to top

Structure, function and genetics

• Al-qattan, MN and Mordi, MN. (2010),
  Docking of sialic acid analogues against influenza A hemagglutinin: a correlational study between experimentally measured and computationally estimated affinities.
  Journal of Molecular Modeling 16(5), 1047-1058.
• Al-qattan, MN and Mordi, MN. (2010),
  Site-directed fragment-based generation of virtual sialic acid databases against influenza A hemagglutinin.
  Journal of Molecular Modeling 16(5), 975-991.
• Arias, CF, Escalera-Zamudio, M, Soto-Del Rio, MD, Cobian-Guemes, AG, Isa, P and Lopez, S. (2009),
  Molecular anatomy of 2009 influenza virus A (H1N1).
  Archives of Medical Research 40(8), 643-654.
• Babakir-Mina, M, Dimonte, S, Ciccozzi, M, Perno, CF and Ciotti, M. (2010),
  The novel swine-origin H1N1 influenza A virus riddle: is it a domestic bird H1N1-derived virus?
  New Microbiologica 33(1), 77-81.
• Glinsky, GV. (2010),
  Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations.
  Cell Cycle 9(5), 958-970.
• Herfst, S, Chutinimitkul, S, Ye, J, de Wit, E, Munster, VJ, Schrauwen, EJA, Bestebroer, TM, Jonges, M, Meijer, A, Koopmans, M, Rimmelzwaan, GF, Osterhaus, ADME, Perez, DR and Fouchier, RAM. (2010),
  Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission.
  Journal of Virology 84(8), 3752-8.
• Kiseleva, IV, Voeten, JTM, Teley, LCP, Larionova, NV, Drieszen-van der Cruijsen, SKM, Basten, SMC, Heldens, JGM, van den Bosch, H and Rudenko, LG. (2010),
  PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus.
  Journal of General Virology 91(Pt 4), 931-7.
• Li, Y, Chan, EY, Li, J, Ni, C, Peng, X, Rosenzweig, E, Tumpey, TM and Katze, MG. (2010),
  MicroRNA expression and virulence in pandemic influenza virus-infected mice.
  Journal of Virology 84(6), 3023-32.
• Matrosovich, M. (2010),
  Receptor specificity and host range of influenza viruses.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 33.
• Memoli, MJ, Hrabal, RJ, Hassantoufighi, A, Jagger, BW, Sheng, ZM, Eichelberger, MC and Taubenberger, JK. (2010),
  Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.
  Journal of Infectious Diseases 201(9), 1397-1403.
• Mendelson, M, Tekoah, Y, Zilka, A, Gershoni-Yahalom, O, Gazit, R, Achdout, H, Bovin, NV, Meningher, T, Mandelboim, M, Mandelboim, O, David, A and Porgador, A. (2010),
  NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus.
  Journal of Virology 84(8), 3789-3797.
• Mochalova, L, Bright, R, Xu, XY, Korchagina, E, Chinarev, A, Bovin, N and Klimov, A. (2010),
  Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors.
  Glycoconjugate Journal 27(3), 321-327.
• Ruiz-Carrascoso, G, Casas, I, Pozo, F, Perez-Gonzalez, C, Reina, J and Perez-Brena, P. (2010),
  Development and implementation of influenza A virus subtyping and detection of genotypic resistance to neuraminidase inhibitors.
  Journal of Medical Virology 82(5), 843-853.
• Sridharan, H, Zhao, C and Krug, RM. (2010),
  Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins.
  Journal of Biological Chemistry 285(11), 7852-6.
• Su, B, Wurtzer, S, Rameix-Welti, M-A, Dwyer, D, van der Werf, S, Naffakh, N, Clavel, F and Labrosse, B. (2009),
  Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).
  PLoS ONE 4(12), e8495.
• Sung, JC, Van Wynsberghe, AW, Amaro, RE, Li, WW and McCammon, JA. (2010),
  Role of secondary sialic acid binding sites in influenza N1 neuraminidase.
  Journal of the American Chemical Society 132(9), 2883-5.
• Takahashi, T, Satoh, H, Takaguchi, M, Takafuji, S, Yokoyama, H, Fujii, S and Suzuki, T. (2010),
  Binding of sulphatide to recombinant haemagglutinin of influenza A virus produced by a baculovirus protein expression system*.
  Journal of Biochemistry 147(4), 459-462.
• Takemae, N, Ruttanapumma, R, Parchariyanon, S, Yoneyama, S, Hayashi, T, Hiramatsu, H, Sriwilaijaroen, N, Uchida, Y, Kondo, S, Yagi, H, Kato, K, Suzuki, Y and Saito, T. (2010),
  Alterations in receptor-binding properties of swine influenza viruses of the H1 subtype after isolation in embryonated chicken eggs.
  Journal of General Virology 91(Pt 4), 938-48.
• Turner, SJ, Brown, LE, Doherty, PC and Kelso, A. (2009),
  Q&A: what have we found out about the influenza A (H1N1) 2009 pandemic virus?
  Journal of Biology 8(8), 69.
• Ueda, M, Daidoji, T, Du, A, Yang, C-S, Ibrahim, MS, Ikuta, K and Nakaya, T. (2010),
  Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells.
  Journal of Virology 84(6), 3068-78.
• Upham, JP, Pickett, D, Irimura, T, Anders, EM and Reading, PC. (2010),
  Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry.
  Journal of Virology 84(8), 3730-3737.
• Van Reeth, K. (2010),
  Zoonotic potential of non-avian influenza A viruses.
  Influenza and Other Respiratory Viruses 4(Suppl. 1), 34.
• Volmer, R, Mazel-Sanchez, B, Volmer, C, Soubies, SM and Guerin, JL. (2010),
  Nucleolar localization of influenza A NS1: striking differences between mammalian and avian cells.
  Virology Journal 7, 63.
• Yan, SM and Wu, G. (2010),
  Prediction of mutation positions in H5N1 neuraminidases from influenza A virus by means of neural network.
  Annals of Biomedical Engineering 38(3), 984-992.
• Zheng, X, Todd, KM, Yen-Lieberman, B, Kaul, K, Mangold, K and Shulman, ST. (2010),
  Unique finding of a 2009 H1N1 influenza virus-positive clinical sample suggests matrix gene sequence variation.
  Journal of Clinical Microbiology 48(2), 665-6.

Back to top

Therapies and antivirals

• Awaad, MHH, Abdel-Alim, GA, Sayed, KSS, Ahmed, KA, Nada, AA, Metwalli, ASZ and Alkhalaf, AN. (2010),
  Immunostimulant effects of essential oils of peppermint and eucalyptus in chickens.
  Pakistan Veterinary Journal 30(2), 61-66.
• Casscells, SW, Granger, E, Kress, AM, Linton, A, Madjid, M and Cottrell, L. (2009),
  Use of oseltamivir after influenza infection is associated with reduced incidence of recurrenta adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases.
  Circulation-Cardiovascular Quality and Outcomes 2(2), 108-U80.
• Chavas, LMG, Kato, R, Suzuki, N, von Itzstein, M, Mann, MC, Thomson, RJ, Dyason, JC, McKimm-Breschkin, J, Fusi, P, Tringali, C, Venerando, B, Tettamanti, G, Monti, E and Wakatsuki, S. (2010),
  Complexity in influenza virus targeted drug design: interaction with human sialidases.
  Journal of Medicinal Chemistry 53(7), 2998-3002.
• Coffin, SE. (2010),
  In response to: optimization of antiviral prescribing for influenza.
  Journal of Hospital Medicine 5(1), E31.
• Dutkowski, R, Smith, JR and Davies, BE. (2010),
  Safety and pharmacokinetics of oseltamivir at standard and high dosages.
  International Journal of Antimicrobial Agents 35(5), 461-467.
• Eggertson, L. (2010),
  Tamiflu still prudent for pandemic influenza, PHAC maintains.
  CMAJ Canadian Medical Association Journal 182(2), E133-4.
• Falagas, ME, Vouloumanou, EK, Baskouta, E, Rafailidis, PI, Polyzos, K and Rello, J. (2010),
  Treatment options for 2009 H1N1 influenza: evaluation of the published evidence.
  International Journal of Antimicrobial Agents 35(5), 421-430.
• Gong, TX, Jiang, Y, Wang, YL, Yang, D, Li, WY, Zhang, Q, Feng, W, Wang, BN, Jiang, ZH and Li, MY. (2010),
  Recombinant mouse β-defensin 2 inhibits infection by influenza A virus by blocking its entry.
  Archives of Virology 155(4), 491-498.
• Hayward, A. (2010),
  Does treatment with oseltamivir prevent transmission of influenza to household contacts?
  Clinical Infectious Diseases 50(5), 715-6.
• Ho, LNL, Chung, JPY and Choy, KLW. (2010),
  Oseltamivir-induced mania in a patient with H1N1.
  American Journal of Psychiatry 167(3), 350.
• Isaacs, D. (2010),
  Oseltamivir and influenza in high-risk children and adolescents.
  Journal of Paediatrics and Child Health 46(3), 129.
• Jagannath, VA, Asokan, GV, Fedorowicz, Z, Singaram, JS and Lee, TWR. (2010),
  Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.
  Cochrane Database of Systematic Reviews (3), Cd008139.
• Kazakova, OB, Tretyakova, EV, Kukovinets, OS, Abdrakhmanova, AR, Kabalnova, NN, Kazakov, DV, Tolstikov, GA and Gubaidullin, AT. (2010),
  Synthesis of nontrivial quinopimaric acid derivatives by oxidation with dimethyldioxirane.
  Tetrahedron Letters 51(14), 1832-1835.
• Kimberlin, DW, Escude, J, Gantner, J, Ott, J, Dronet, M, Stewart, TA, Jester, P, Redden, DT, Chapman, W and Hammond, R. (2010),
  Targeted antiviral prophylaxis with oseltamivir in a summer camp setting.
  Archives of Pediatrics & Adolescent Medicine 164(4), 323-327.
• Kimura, Y, Yamatsugu, K, Kanai, M, Echigo, N, Kuzuhara, T and Shibasaki, M. (2010),
  Design and synthesis of resin-conjugated Tamiflu analogs for affinity chromatography.
  Bulletin of the Korean Chemical Society 31(3), 588-594.
• Kwiatek, M, Kocik, J and Bartoszcze, M. (2009),
  [The substances active against influenza virus. Possibilities and prospects of application].
  Przeglad Epidemiologiczny 63(4), 487-94.
• Loginova, SI, Borisevich, SV, Semenova, IA, Borisevich, GV, Maksimov, VA, Bondarev, VP and Nebol'sin, VE. (2009),
  [In vitro investigation of Ingavirin efficacy against influenza B virus].
  Antibiotiki i Khimioterapiia 54(7-8), 13-5.
• Matsuzaki, Y, Mizuta, K, Aoki, Y, Suto, A, Abiko, C, Sanjoh, K, Sugawara, K, Takashita, E, Itagaki, T, Katsushima, Y, Ujike, M, Obuchi, M, Odagiri, T and Tashiro, M. (2010),
  A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
  Virology Journal 7, 53.
• Ng, S, Cowling, BJ, Fang, VJ, Chan, KH, Ip, DKM, Cheng, CKY, Uyeki, TM, Houck, PM, Malik Peiris, JS and Leung, GM. (2010),
  Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus.
  Clinical Infectious Diseases 50(5), 707-14.
• Ngoc, DT, Albicker, M, Schneider, L and Cramer, N. (2010),
  Enantioselective assembly of the benzo[d]xanthene tetracyclic core of anti-influenza active natural products.
  Organic & Biomolecular Chemistry 8(8), 1781-1784.
• Okamoto, E. (2010),
  Is oseltamivir (Tamiflu) safe? Re-examining the Tamiflu 'ado' from Japan.
  Expert Review of Pharmacoeconomics & Outcomes Research 10(1), 17-24.
• Rao, JR, Jha, AK, Rawal, RK, Sharon, A, Day, CW, Barnard, DL, Smee, DF and Chu, CK. (2010),
  (-)-Carbodine: enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu).
  Bioorganic & Medicinal Chemistry Letters 20(8), 2601-2604.
• Rosenborg, S. (2010),
  [Can oseltamivir (Tamiflu) be used in dialysis-requiring renal failure?].
  Lakartidningen 107(3), 116-7.
• Shih, SR, Chu, TY, Reddy, GR, Tseng, SN, Chen, HL, Tang, WF, Wu, MS, Yeh, JY, Chao, YS, Hsu, JTA, Hsieh, HP and Horng, JT. (2010),
  Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.
  Journal of Biomedical Science 17, 13.
• Shin, W-J, Lee, K-H, Park, M-H and Seong, B-L. (2010),
  Broad-spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses.
  Microbiology & Immunology 54(1), 11-9.
• Sologub, TV, Shul'diakov, AA, Romantsov, MG, Zhekalov, AN, Petlenko, SV, Erofeeva, MK, Maksakova, VL, Isakov, VA, Zarubaev, VV, Gatsan, VV and Kovalenko, AL. (2010),
  [Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)].
  Antibiotiki i Khimioterapiia 54(7-8), 30-2.
• Tung, NH, Kwon, HJ, Kim, JH, Ra, JC, Kim, JA and Kim, YH. (2010),
  An anti-influenza component of the bark of Alnus japonica.
  Archives of Pharmacal Research 33(3), 363-367.
• Yamaya, M, Shinya, K, Hatachi, Y, Kubo, H, Asada, M, Yasuda, H, Nishimura, H and Nagatomi, R. (2010),
  Clarithromycin inhibits type A seasonal influenza virus infection in human airway epithelial cells.
  Journal of Pharmacology and Experimental Therapeutics 333(1), 81-90.
• Yasuda, T, Yamaki, M, Iimura, A, Shimotai, Y, Shimizu, K, Noshita, T and Funayama, S. (2010),
  Anti-influenza virus principles from Muehlenbeckia hastulata.
  Journal of Natural Medicines 64(2), 206-211.
• Zaraket, H, Saito, R, Suzuki, Y, Baranovich, T, Dapat, C, Caperig-Dapat, I and Suzuki, H. (2010),
  Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.
  Journal of Clinical Microbiology 48(4), 1085-1092.
• Zhiqiang, W, Yaowu, Y, Fan, Y, Jian, Y, Yongfeng, H, Lina, Z, Jianwei, W and Qi, J. (2010),
  Effective siRNAs inhibit the replication of novel influenza A (H1N1) virus.
  Antiviral Research 85(3), 559-561.

Back to top

Vaccination and vaccines

• Anonymous. (2010),
  Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
  Weekly Epidemiological Record 85(11), 100-7.
• Anonymous. (2010),
  Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season.
  Weekly Epidemiological Record 85(10), 81-92.
• Amendola, A, Pariani, E, Vigano, A, Erba, P, Zappa, A, Giacomet, V, Tanzi, E, Zuccotti, GV and Zanetti, A. (2010),
  Influenza surveillance in a cohort of HIV-infected children and adolescents immunized against seasonal influenza.
  Vaccine 28(15), 2700-2704.
• Aranda-Romo, S, Comas-Garcia, A, Garcia-Sepulveda, CA, Hernandez-Salinas, AE, Pina-Ramirez, M and Noyola, DE. (2010),
  Effect of an immunization program on seasonal influenza hospitalizations in Mexican children.
  Vaccine 28(13), 2550-2555.
• Baeyens, JP. (2010),
  Ensuring the willingness to vaccinate and be vaccinated.
  Expert Review of Vaccines 9(3), 11-14.
• Baguelin, M, Van Hoek, AJ, Jit, M, Flasche, S, White, PJ and Edmunds, WJ. (2010),
  Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
  Vaccine 28(12), 2370-2384.
• Belshe, RB, Coelingh, K, Ambrose, CS, Woo, JC and Wu, XH. (2010),
  Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
  Vaccine 28(9), 2149-2156.
• Ben-Yedidia, T. (2010),
  Multimeric-001: BiondVax's universal flu vaccine.
  Expert Review of Vaccines 9(3), 241-242.
• Bhakdi, S, Lackner, K and Doerr, H-W. (2009),
  Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed?
  Medical Microbiology & Immunology 198(4), 205-9.
• Bolam, B and Grills, N. (2009),
  Adverse effects following pandemic influenza (H1N1) 2009 vaccination.
  Australian & New Zealand Journal of Public Health 33(6), 584.
• Brahmakshatriya, VR, Lupiani, B and Reddy, SM. (2010),
  Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens.
  Vaccine 28(12), 2388-2396.
• Caban-Martinez, AJ, Lee, DJ, Davila, EP, LeBlanc, WG, Arheart, KL, McCollister, KE, Christ, SL, Clarke, T and Fleming, LE. (2010),
  Sustained low influenza vaccination rates in US healthcare workers.
  Preventive Medicine 50(4), 210-212.
• Cai, Y, Rodriguez, S, Rameswaran, R, Draghia-Akli, R, Juba, RJ and Hebel, H. (2010),
  Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage.
  Vaccine 28(8), 2046-2052.
• Cate, TR, Rayford, Y, Nino, D, Winokur, P, Brady, R, Belshe, R, Chen, W, Atmar, RL and Couch, RB. (2010),
  A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.
  Vaccine 28(9), 2076-2079.
• Centers for Disease Control and Prevention. (2010),
  Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination coverage among health-care personnel - United States, August 2009-January 2010.
  MMWR - Morbidity & Mortality Weekly Report 59(12), 357-62.
• Centers for Disease Control and Prevention. (2010),
  Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010.
  MMWR - Morbidity & Mortality Weekly Report 59(12), 363-8.
• Chen, Y, Wu, J and Yi, QL. (2010),
  Reduced risk of hospitalization associated with influenza vaccination in Canada.
  Vaccine 28(11), 2290-2295.
• Chi, R-C, Reiber, GE, Lipsky, BA, Boyko, EJ and Neuzil, KM. (2010),
  Influenza vaccination rates of children in households with high-risk adults.
  Public Health Reports 125(2), 192-8.
• deSante, JE, Caplan, A, Shofer, F and Behrman, AJ. (2010),
  Physician attitudes towards influenza immunization and vaccine mandates.
  Vaccine 28(13), 2517-2521.
• Donmez, L, Polat, HH, Yalcin, AN, Oncel, S and Turhan, O. (2010),
  Influenza vaccination: rates, knowledge and the attitudes of physicians in a university hospital.
  Turkiye Klinikleri Tip Bilimleri Dergisi 30(1), 48-53.
• Eggertson, L. (2010),
  Egg-allergic patients gain greater access to H1N1 vaccine after completion of clinical trial.
  CMAJ Canadian Medical Association Journal 182(2), E99-100.
• Eisenberg, S. (2010),
  H1N1 vaccination keeps you and your patients safe.
  ONS Connect 25(2), 8.
• Esteves-Jaramillo, A, Omer, SB, Gonzalez-Diaz, E, Salmon, DA, Hixson, B, Navarro, F, Kawa-Karasik, S, Frew, P, Morfin-Otero, R, Rodriguez-Noriega, E, Ramirez, Y, Rosas, A, Acosta, E, Varela-Badillo, V and Del Rio, C. (2009),
  Acceptance of a vaccine against novel influenza A (H1N1) virus among health care workers in two major cities in Mexico.
  Archives of Medical Research 40(8), 705-711.
• Ford, S. (2010),
  H1N1 vaccine. Four SHAs have swine flu jab deals in place.
  Health Service Journal 120(6188), 9.
• Geeraedts, F, Saluja, V, ter Veer, W, Amorij, JP, Frijlink, HW, Wilschut, J, Hinrichs, WLJ and Huckriede, A. (2010),
  Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.
  AAPS Journal 12(2), 215-222.
• Jameson, M. (2009),
  A practical comparison of the 2009 versus 1976 swine flu vaccines.
  Maryland Medicine 10(3), 24-6.
• Janjua, NZ, Skowronski, DM, Hottes, TS, De Serres, G, Crowcroft, NS and Rosella, LC. (2010),
  Seasonal vaccine effectiveness against pandemic A/H1N1.
  Lancet 375(9717), 801-2; author reply 802-3.
• Joo, HM, He, YX, Sundararajan, A, Huan, LF and Sangster, MY. (2010),
  Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination.
  Vaccine 28(10), 2186-2194.
• Kanaoka, S. (2010),
  [Inpatient and personnel vaccination influence on influenza outbreaks in long-term medical and care hospital].
  Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases 84(1), 14-8.
• Keeton, VF and Chen, AK. (2010),
  Immunization updates and challenges.
  Current Opinion in Pediatrics 22(2), 234-240.
• Khan, AO. (2009),
  Recurrent isolated sixth nerve palsy after consecutive annual influenza vaccination in a child.
  Journal of AAPOS: American Association for Pediatric Ophthalmology & Strabismus 13(6), 623.
• Kim, YC, Quan, FS, Compans, RW, Kang, SM and Prausnitz, MR. (2010),
  Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
  Journal of Controlled Release 142(2), 187-195.
• Krashias, G, Simon, AK, Wegmann, F, Kok, WL, Ho, LP, Stevens, D, Skehel, J, Heeney, JL, Moghaddam, AE and Sattentau, QJ. (2010),
  Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.
  Vaccine 28(13), 2482-2489.
• Kuehn, BM. (2010),
  CDC Advisory Committee recommends nearly universal influenza vaccination.
  JAMA-Journal of the American Medical Association 303(12), 1136.
• Kwong, JC, Ge, H, Rosella, LC, Guan, J, Maaten, S, Moran, K, Johansen, H and Guttmann, A. (2010),
  School-based influenza vaccine delivery, vaccination rates, and healthcare use in the context of a universal influenza immunization program: an ecological study.
  Vaccine 28(15), 2722-2729.
• Li, GX, Zhou, YJ, Yu, H, Tian, ZJ, Yan, LP, Zhang, Q, Hu, SP and Tong, GZ. (2010),
  Prime-boost immunization with HA/C3d DNA followed by a recombinant pseudorabies virus boost enhanced protective immunity against H3N2 swine influenza virus in mice.
  Research in Veterinary Science 88(2), 345-351.
• Li, Y and Mukamel, DB. (2010),
  Racial disparities in receipt of influenza and pneumococcus vaccinations among US nursing-home residents.
  American Journal of Public Health 100(Suppl 1 ), S256-S262.
• Maggi, S. (2010),
  Vaccination and healthy aging.
  Expert Review of Vaccines 9(3), 3-6.
• Manzoli, L, Villari, P, Granchelli, C, Savino, A, Carunchio, C, Alessandrini, M, Palumbo, F, De Vito, C, Schioppa, F, Di Stanislao, F and Boccia, A. (2009),
  Influenza vaccine effectiveness for the elderly: a cohort study involving general practitioners from Abruzzo, Italy.
  Journal of Preventive Medicine & Hygiene 50(2), 109-12.
• Maurer, J and Harris, KM. (2010),
  The scope and targeting of influenza vaccination reminders among US adults: evidence from a nationally representative survey.
  Archives of Internal Medicine 170(4), 390-2.
• McEnery, R. (2009),
  Vaccine considerations for H1N1.
  IAVI Report: Newsletter on International AIDS Vaccine Research 13(3), 14.
• Meshcheriakova, IA, El'darov, MA, Migunov, AI, Stepanova, LA, Repko, IA, Kiselev, OI, Lomonosov, DP and Skriabin, KG. (2009),
  [Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics].
  Molekuliarnaia Biologiia 43(4), 741-50.
• Michel, JP. (2010),
  Updated vaccine guidelines for aging and aged citizens of Europe.
  Expert Review of Vaccines 9(3), 7-10.
• Miyaki, C, Quintilio, W, Miyaji, EN, Botosso, VF, Kubrusly, FS, Santos, FL, Iourtov, D, Higashi, HG and Raw, I. (2010),
  Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations.
  Vaccine 28(13), 2505-2509.
• Osman, AD. (2010),
  Reasons for and barriers to influenza vaccination among healthcare workers in an Australian emergency department.
  Australian Journal of Advanced Nursing 27(3), 38-43.
• Pan, ZM, Zhang, XM, Geng, SZ, Fang, Q, You, M, Zhang, L, Jiao, XN and Liu, XF. (2010),
  Prime-boost immunization using a DNA vaccine delivered by attenuated Salmonella enterica serovar Typhimurium and a killed vaccine completely protects chickens from H5N1 highly pathogenic avian influenza virus.
  Clinical and Vaccine Immunology 17(4), 518-523.
• Payaprom, Y, Bennett, P, Burnard, P, Alabaster, E and Tantipong, H. (2010),
  Understandings of influenza and influenza vaccination among high-risk urban dwelling Thai adults: a qualitative study.
  Journal of Public Health 32(1), 26-31.
• Prato, R, Tafuri, S, Fortunato, F and Martinelli, D. (2010),
  Vaccination in healthcare workers: an Italian perspective.
  Expert Review of Vaccines 9(3), 277-283.
• Rao, SS, Kong, WP, Wei, CJ, Van Hoeven, N, Gorres, JP, Nason, M, Andersen, H, Tumpey, TM and Nabel, GJ. (2010),
  Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret.
  PLoS ONE 5(3), e9812.
• Richard, SA, Viboud, C and Miller, MA. (2010),
  Evaluation of Southern Hemisphere influenza vaccine recommendations.
  Vaccine 28(15), 2693-2699.
• Roman, F, Vaman, T, Gerlach, B, Markendorf, A, Gillard, P and Devaster, J-M. (2010),
  Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
  Vaccine 28(7), 1740-5.
• Saluja, V, Amorij, JP, van Roosmalen, ML, Leenhouts, K, Huckriede, A, Hinrichs, WLJ and Frijlink, HW. (2010),
  Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant.
  AAPS Journal 12(2), 109-116.
• Samadani, AM. (2009),
  HIN1 vaccine shortage and distribution mismanagement.
  WMJ 108(9), 430.
• Santibanez, TA, Mootrey, GT, Euler, GL and Janssen, AP. (2010),
  Behavior and beliefs about influenza vaccine among adults aged 50-64 years.
  American Journal of Health Behavior 34(1), 77-89.
• Schmeisser, F, Vodeiko, GM, Lugovtsev, VY, Stout, RR and Weir, JP. (2010),
  An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
  Vaccine 28(12), 2442-2449.
• Schmitt, H-J, Gregersen, JP, Trusheim, H and Broker, M. (2010),
  [Safety of cell culture-based influenza vaccines].
  Medizinische Monatsschrift fur Pharmazeuten 33(1), 4-10.
• Schoub, BD. (2010),
  Recommendations pertaining to the use of viral vaccines: influenza 2010.
  SAMJ South African Medical Journal 100(2), 88-89.
• Schwarzinger, M, Verger, P, Guerville, MA, Aubry, C, Rolland, S, Obadia, Y and Moatti, JP. (2010),
  Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public?
  Vaccine 28(15), 2743-2748.
• Shahgholi, E, Ehsani, MA, Salamati, P, Maysamie, A, Sotoudeh, K and Mokhtariazad, T. (2010),
  Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy.
  Pediatric Blood & Cancer 54(5), 716-720.
• Shahrabani, S and Benzion, U. (2010),
  Workplace vaccination and other factors impacting influenza vaccination decision among employees in Israel.
  International Journal of Environmental Research and Public Health 7(3), 853-869.
• Shim, DH, Ko, HJ, Volker, G, Potter, AA, Mutwiri, G, Babiuk, LA and Kweon, MN. (2010),
  Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens.
  Vaccine 28(11), 2311-2317.
• Sindoni, D, La Fauci, V, Squeri, R, Cannavo, G, Bacilieri, S, Panatto, D, Gasparini, R and Amicizia, D. (2009),
  Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
  Journal of Preventive Medicine & Hygiene 50(2), 121-6.
• Smith, LR, Wloch, MK, Ye, M, Reyes, LR, Boutsaboualoy, S, Dunne, CE, Chaplin, JA, Rusalov, D, Rolland, AP, Fisher, CL, Al-Ibrahim, MS, Kabongo, ML, Steigbigel, R, Belshe, RB, Kitt, ER, Chu, AH and Moss, RB. (2010),
  Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
  Vaccine 28(13), 2565-2572.
• Song, XM, Chen, J, Sakwiwatkul, K, Li, RL and Hu, SH. (2010),
  Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re.
  International Immunopharmacology 10(3), 351-356.
• Stech, J. (2010),
  Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984.
  Expert Opinion on Therapeutic Patents 20(3), 447-450.
• Sui, Z, Chen, Q, Wu, R, Zhang, H, Zheng, M, Wang, H and Chen, Z. (2010),
  Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
  Archives of Virology 155(4), 535-44.
• Talbot, TR, Dellit, TH, Hebden, J, Sama, D and Cuny, J. (2010),
  Factors associated with increased healthcare worker influenza vaccination rates: results from a national survey of university hospitals and medical centers.
  Infection Control and Hospital Epidemiology 31(5), 456-462.
• Tissot, AC, Renhofa, R, Schmitz, N, Cielens, I, Meijerink, E, Ose, V, Jennings, GT, Saudan, P, Pumpens, P and Bachmann, MF. (2010),
  Versatile virus-like particle carrier for epitope based vaccines.
  PLoS ONE 5(3), e9809.
• Tosh, PK, Jacobson, RM and Poland, GA. (2010),
  Influenza vaccines: from surveillance through production to protection.
  Mayo Clinic Proceedings 85(3), 257-273.
• Tropper, J, Shimabukuro, T, Sapkota, S, Williams, W, Williams, CE, Stanley, T, Andujar, U, Gallagher, T, Han-Lee, L and Hill, H. (2009),
  CDC's countermeasure and response administration system for monitoring H1N1 vaccine doses administered.
  Disaster Medicine & Public Health Preparedness 3(Suppl 2), S107-8.
• Valdespino-Gomez, JL, Garcia-Garcia, L and de Leon-Rosales, SP. (2009),
  Vaccines against influenza A (H1N1) pandemic.
  Archives of Medical Research 40(8), 693-704.
• van Maurik, A, Sabarth, N, Dacho, HS, Bruhl, P, Schwendinger, M, Crowe, BA, Noel Barrett, P, Kistner, O and Keith Howard, M. (2010),
  Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination.
  Vaccine 28(7), 1778-85.
• Vesely, R. (2009),
  The cost of H1N1. Payers hope vaccine availability will help ease costs.
  Modern Healthcare 39(44), 10.
• Vincent, AL, Ciacci-Zanella, JR, Lorusso, A, Gauger, PC, Zanella, EL, Kehrli, ME, Janke, BH and Lager, KM. (2010),
  Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.
  Vaccine 28(15), 2782-2787.
• Vrijhoef, HJM, Janssen, JJM and Greenberg, ME. (2009),
  Feasibility of telemonitoring for active surveillance of influenza vaccine safety in the primary care setting in The Netherlands.
  Journal of Telemedicine & Telecare 15(7), 362-7.
• Weinberg, A, Song, L-Y, Fenton, T, Nachman, SA, Read, JS, Patterson-Bartlett, J and Levin, MJ. (2010),
  T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines.
  AIDS Research & Human Retroviruses 26(1), 51-9.
• Wu, CY, Yeh, YC, Yang, YC, Chou, C, Liu, MT, Wu, HS, Chan, JT and Hsiao, PW. (2010),
  Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus.
  PLoS ONE 5(3), e9784.
• Wu, J, Zhang, F, Fang, F, Chang, H, Wang, F, Yang, Z, Sun, B and Chen, Z. (2010),
  Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.
  Vaccine 28(15), 2775-2781.
• Xie, Y, Sun, HX and Li, D. (2010),
  Platycodin D improves the immunogenicity of Newcastle disease virus-based recombinant avian influenza vaccine in mice.
  Chemistry & Biodiversity 7(3), 677-689.